FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2010/091/000140 [Registered on: 23/02/2010]
Last Modified On: 27/08/2013
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study
Modification(s)  
Drug 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study
Modification(s)  
The purpose of this study is to determine whether cariprazine is safe and effective in the treatment of patients with acute mania associated with Bipolar I disorder. 
Scientific Title of Study
Modification(s)  
A Double-blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder. 
Trial Acronym   
Secondary IDs if Any
Modification(s)  
Secondary ID  Identifier 
NCT01058096   ClinicalTrials.gov 
RGH-MD-32   Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Modification(s)  
Name   
Designation   
Affiliation   
Address 




 
Phone    
Fax    
Email    
 
Details of Contact Person
Scientific Query

Modification(s)  
Name  Dr Shoibal Mukherjee 
Designation  Vice President, Medical  
Affiliation  Quintiles Research (India) Pvt. Ltd. 
Address  8th Floor, DLF Square M Block, Jacaranda Marg DLF City Phase II Gurgaon, Haryana India - 122002

Gurgaon
HARYANA
122002
India 
Phone  91-7838652395  
Fax    
Email  shoibal.mukherjee@quintiles.com  
 
Details of Contact Person
Public Query

Modification(s)  
Name  Suchela Srivatsa 
Designation  Director – Clinical Operations  
Affiliation  Quintiles Research India Pvt. Ltd. 
Address  301-A-1, Leela Business Park MV Road, Andheri East, Mumbai 400059

Mumbai
MAHARASHTRA
400059
India 
Phone  91-9820712114  
Fax  91-22-56774343  
Email  suchela.srivatsa@quintiles.com  
 
Source of Monetary or Material Support
Modification(s)  
Forest Research Institute Harborside Financial Center, Plaza 5 Jersey City, NJ, USA, 07311  
Gedeon Richter Plc. Gyömrői út 19-21. Budapest Hungary 1103 
 
Primary Sponsor
Modification(s)  
Name  Forest Research Institute  
Address  Harborside Financial Center, Plaza 5Jersey City, NJ, USA, 07311 
Type of Sponsor  Pharmaceutical industry-Global 
 
Details of Secondary Sponsor
Modification(s)  
Name  Address 
Quintiles Research India Private Limited   B-101-106, Shapath IV, Opp. Karnavati Club, Sarkhej – Gandhinagar Road, Ahmedabad 380 051 
 
Countries of Recruitment
Modification(s)  
  India
United States of America  
Sites of Study
Modification(s)  
No of Sites = 18  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr. Anjanappa Jagadish  Abhaya Hospital, Bangalore  Abhaya Hospital, M.H. Marigowda road,,Wilson Garden-560027
Bangalore
KARNATAKA 
+91 9844059066
91 80 26566767
a_jagadish@yahoo.com 
Dr. Sanjay Phadke  Deenanath Mangeshkar Hospital and Research Centre, Pune  Deenanath Mangeshkar Hospital and Research Centre,Erandawane-411004
Pune
MAHARASHTRA 
+91 9823262786
+91 20 66023105
sanjay_phadke@hotmail.com 
Dr. Venu Gopal Jhanwar  Deva Mental Health care, Varanasi  Deva Mental Health care,B27/70, MN, Durgakund-221005
Varanasi
UTTAR PRADESH 
+91 9936611111
+91 542 2310510
venugj@gmail.com 
Dr. R. C. Maniar  Gujarat Institute of Psychological Sciences and Research center, Ahmedabad  Gujarat Institute of Psychological Sciences and Research center,Shreenath Complex, Opp-punitnagar Society, Umiyavijay Road, Satellite-380015
Ahmadabad
GUJARAT 
+91 9824011933
+91 79 26608498
rcmaniar@yahoo.com 
Dr. T. S. Sathyanarayana Rao  J.S.S. Medical College Hospital, Mysore  J.S.S Medical College Hospital,M.G. Road-570004
Mysore
KARNATAKA 
+91 9845085561
+91 821 2442840
tssrao19@yahoo.com 
Dr. Sateesh Rao  K.S. Hegde Medical Academy, Mangalore   K.S. Hegde Medical Academy,Deralakatte-575018
Bangalore
KARNATAKA 
+91 9845085561
+91 824 2202733
drsateeshrao@yahoo.com 
Dr. Podila Satya Venkata Narasimha Sharma  Kasturba Hospital, Manipal  Kasturba Hospital,-576104

 
+91 820 2922217
+91 820 2571930
psvn.sharma@manipal.edu 
Dr. R. Sathianathan  Madras Medical College and Government General Hospital, Chennai  Madras Medical College and Government General Hospital,Department of Psychiatry-600001
Chennai
TAMIL NADU 
+91 9841019910
+91 44 25384212
sathianathen6@yahoo.com 
Dr Nadukuru Nooka Raju  Maharshi Institute of Neuro Psychological Disorders (MIND)   101 Vishnu Suryaprabha Paradize, KGH Up Road, Maharani Peta, Vishakhapatnam - 530002
Visakhapatnam
ANDHRA PRADESH 
0984-9111505
0891-2724348
drnnraju@yahoo.com 
Dr. Ramesh Kumar Mahendru  Mahendru Psychiatric centre, Kanpur  Mahendru Psychiatric centre,117/40 Sarvodaya Nagar-200005

 
+91 9839032699
+91 512 22420343
rkmahendru@indiatimes.com 
Dr. Ravish Thunga  Manaswini Thunga Institute of Psychiatry & Counselling, Mangalore  Manaswini Thunga Institute of Psychiatry & Counselling,Jyothi Circle, Balmatta-575001
Bangalore
KARNATAKA 
+91 9845263090
+91 824 2445034
ravishthunga@yahoo.com 
Dr. Jitendra Kumar Trivedi  Manobal Medical Research Center Pvt Ltd., Lucknow  Manobal Medical Research Center Pvt Ltd,B-8, Sector-A, Mahanagar-226006
Lucknow
UTTAR PRADESH 
+91 522 2651173
+91 522 2260173
jitendra.trivedi@gmail.com 
Dr. Mahesh Chudgar  MITR Foundation, Ahmedabad  MITR Foundation, 1, Shantinagar society,Ashram road-380013
Ahmadabad
GUJARAT 
+91 9825412109
+ 91 79 27552623
mahesh_mitr@yahoo.co.in 
Dr. Dattatreya Madhav Dhavale  Poona Hospital and Research Centre,   27, Sadashiv Peth, ,-411030
Pune
MAHARASHTRA 
91 9822028286
91 20 24337777
dattatreyad@yahoo.com 
Dr. Vinay Laxmikantrao Barhale  Shanti nursing Home, Aurangabad  Shanti nursing Home, Kanchanwadi, ,Paithan Road-431005
Aurangabad
BIHAR 
+91 9860798041
+91 240 2377631
vinay.barhale@rediffmail.com 
Dr. Mahesh R. Gowda  Spandana Nursing Home, Bangalore  Spandana Nursing Home,Rajajinagar-560010
Bangalore
KARNATAKA 
+91 9845134915
+91 80 23141028
maheshrgowda@yahoo.com 
Dr. Umesh Nagapurkar  Sujata Birla Hospital & Medical Research Center, Nasik  Sujata Birla Hospital & Medical Research Center,Opp. Bytco college-422101

 
+91 9823146088
+91 253 2454254
umeshanjali@gmail.com 
Dr. Vishal Indla  Vijayawada Institute of Mental Health and Neurosciences (VIMHANS), Vijayawada  Vijayawada Institute of Mental Health and Neurosciences (VIMHANS),,V.V. Rao street, Suryarao Pet-520002

 
+91 9704755669
+91 866 2444999
vishalindla@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 18  
Name of Committee  Approval Status 
Abhaya Ethics Committee, Bangalore- Dr. Anjanappa Jagadish  Approved 
Central Ethics Committee - Nittie University, Mangalore- Dr. Satheesh Rao  Approved 
DMHC Ethics Committee, Varanasi- Dr. Venu Gopal Jhanwar  Approved 
Ethics Committee - J.S.S Medical College Hospital, Mysore- Dr. T. S. Sathyanarayana Rao  Approved 
Ethics Committee - Kasturba Hospital, Manipal- Dr. Podila Satya Venkata Narasimha Sharma   Approved 
Ethics Committee - MITR Foundation, Ahmedabad- Dr. Mahesh Chudgar   Approved 
Ethics Committee - Poona Hospital and Research Centre, Pune- Dr. Dattatreya Madhav Dhavale   Approved 
Ethics Committee, Shanti Nursing Home, Aurangabad- Dr. Vinay Laxmikantrao Barhale   Approved 
Independent Ethics Committee, Lucknow- Dr. Jitendra Kumar Trivedi  Approved 
Institutional Ethics Committee - Andhra Medical College, Vishakhapatnam- Dr Nadukuru Nooka Raju  Approved 
Institutional Ethics Committee - Deenanath Mangeshkar Hospital and Research Centre, Pune- Dr. Sanjay Phadke   Approved 
Mahendru Psychiatric Centre Ethics Committee, Kanpur- Dr. Ramesh Kumar Mahendru   Approved 
Mallikatta Ethical Committee, Mangalore- Dr. Ravish Thunga  Approved 
North Maharashtra Ethics Committee, Nasik- Dr. Umesh Nagapurkar   Approved 
Safe Search Independent Ethics Committee, Ahmedabad- Dr. R. C. Maniar  Approved 
Spandana Ethics Committee, Bangalore- Dr. Mahesh R. Gowda   Approved 
The Ethics Committee - Madras Medical College and Government General Hospital, Chennai - Dr. R. Sathianathan   Approved 
VIMHANS-Ethics Committee, Vijayawada- Dr. Vishal Indla  Approved 
 
Regulatory Clearance Status from DCGI
Modification(s)  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  Acute Mania associated with Bipolar I Disorder,  
 
Intervention / Comparator Agent
Modification(s)  
Type  Name  Details 
Intervention  Cariprazine  3-12mg/day Oral Administration 
Comparator Agent  Placebo   
 
Inclusion Criteria
Modification(s)  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  (1) Male or female inpatient, 18 to 65 years of age
(2) Patients who have provided informed consent prior to any study specific procedures
(3) Patients currently meeting the DSM-IV-TR criteria for bipolar I disorder as confirmed by the SCID, manic or mixed type with or without psychotic symptoms
(4) Voluntarily hospitalized for current manic episode
 
 
ExclusionCriteria 
Details  (1) Patients with a DSM-IV-TR diagnosis of an axis I disorder other than bipolar I disorder that was the primary focus of treatment within the previous six months (2) Patients with clinically significant abnormalities on physical examination, laboratory, vital signs, and/ or ECG  
 
Method of Generating Random Sequence
Modification(s)  
Computer generated randomization 
Method of Concealment
Modification(s)  
Pre-numbered or coded identical Containers 
Blinding/Masking
Modification(s)  
Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome
Modification(s)  
Outcome  TimePoints 
Young Mania Rating Scale (YMRS)   3 Weeks 
 
Secondary Outcome
Modification(s)  
Outcome  TimePoints 
Clinical Global Impression-Severity (CGI-S)  3 Weeks 
 
Target Sample Size
Modification(s)  
Total Sample Size="320"
Sample Size from India="160" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial
Modification(s)  
Phase 3 
Date of First Enrollment (India)
Modification(s)  
20/03/2010 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  09/02/2010 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial
Modification(s)  
Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
None 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
This is a multinational, multicenter randomized, double-blind, placebo-controlled, parallel-group, fixed/flexible dose study to evaluate the efficacy, safety, and tolerability of cariprazine monotherapy versus placebo for the treatment of acute manic or mixed episodes associated with bipolar I disorder. The study will be a total of 6 weeks in duration: a no-drug screening period of up to 4 to 7 days, followed by 3 weeks of double-blind treatment and a 2-week safety follow-up period. The primary outcome measure is the YMRS and the secondary outcome measure is the CGI-S. This study will be performed at approximately 40 study centers located in and outside the United States. Globally the enrollment target is 320 patients. In India the enrollment target is 160 patients. The date of first patient enrollment in India is March 23, 2010. 
Close